US Stocks
/
Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Share Price
Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Share Price

Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Share Price

NASDAQ: CYCCP
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Share Price Chart

$0.00$0.00
L
Show Current Price
H

Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-2.09
Revenue (TTM)
$43000.00
Return On Equity (TTM)
515.73%
Profit Margin
-26074.42%
Debt to Equity
-2.88
Quarterly Earnings Growth YoY
97.25%

Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025
RevenueN/A$4000.00$10000.00N/A
Net Profit-$2.95M-$3.26M-$1.96M-$81000.00
Net Profit MarginN/A-81425.00%-19570.00%N/A
Income ChangeN/A-10.56%39.91%95.86%

Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Annual Profit & Loss

All figures in USD

Particulars20222024
Revenue$0.00$43000.00
Net Profit-$21.20M-$11.21M
Net Profit MarginN/A-26074.42%
Income ChangeN/A47.11%

About Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock Historical Returns

MonthOpenCloseChange %

CYCCP Share Price FAQs

What is Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock share price today?

chevron-up
Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock share price today is $0.00 as on August 11, 2026 at 10:55 am IST.

What is the 52 week high and 52 week low of Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock stock?

chevron-up
52 week high/low data for Cyclacel Pharmaceuticals, Inc. 6% Convertible Preferred Stock is currently unavailable.

What is CYCCP's net income for the last quarter?

chevron-up
CYCCP's net income for the last quarter is -0.00B USD.

Can I buy CYCCP shares in India?

chevron-up
Yes. You can buy CYCCP in India by opening an international trading account.